Topic

Florida

A collection of 422 issues

Cigna's Coverage Criteria for Trikafta in Florida: What Counts as "Medically Necessary"?

Answer Box: Getting Trikafta Covered by Cigna in Florida Cigna requires prior authorization (PA) for Trikafta in Florida with documented cystic fibrosis diagnosis (ICD-10 E84.0), confirmed CFTR genotype (F508del or responsive mutations), and prescription from a CF specialist. Standard PA review takes 5 business days; expedited review available for

How to Get Increlex (Mecasermin) Covered by Aetna CVS Health in Florida: Complete Prior Authorization Guide

Quick Answer: Getting Increlex (Mecasermin) Covered by Aetna CVS Health in Florida Aetna CVS Health covers Increlex (mecasermin) for Florida children with severe primary IGF-1 deficiency when specific criteria are met. Your pediatric endocrinologist must submit prior authorization showing height ≥3 standard deviations below normal, IGF-1 levels ≥3 SD below

Renewing Naglazyme (Galsulfase) Approval with Aetna (CVS Health) in Florida: Complete Guide to Prior Authorization Renewal

Answer Box: Renewing Naglazyme (Galsulfase) Coverage with Aetna (CVS Health) in Florida Aetna requires annual prior authorization renewal for Naglazyme (galsulfase) with documented clinical response to therapy. Start your renewal 60-90 days before expiration to avoid treatment gaps. Key requirements include: (1) confirmation of clinically positive response showing improvement, stabilization,

Myths vs. Facts: Getting Eylea and Lucentis Covered by Humana in Florida (Complete Appeals Guide)

Answer Box: Getting Eylea/Lucentis Covered by Humana in Florida Myth: A doctor's prescription guarantees Humana will cover Eylea or Lucentis. Fact: Humana requires prior authorization with specific documentation including OCT imaging, visual acuity data, and often step therapy with bevacizumab first. In Florida, you have 65 days

How Long Does It Take to Get Hetlioz (tasimelteon) Approved by Aetna (CVS Health) in Florida? Complete Timeline Guide

Answer Box: Hetlioz (Tasimelteon) Approval Timeline with Aetna in Florida Standard timeline: 30-45 days maximum for Aetna (CVS Health) prior authorization decisions in Florida, with urgent cases decided within 72 hours. Most complete submissions are processed within 7-10 days. Key requirements: diagnosis by sleep specialist, documented melatonin failure (≥6 months)

Blue Cross Blue Shield Florida's Coverage Criteria for Opfolda (miglustat): What Counts as "Medically Necessary"?

Answer Box: Getting Opfolda (miglustat) Approved by Blue Cross Blue Shield in Florida Quick Answer: Opfolda requires prior authorization from Blue Cross Blue Shield Florida and must be prescribed with Pombiliti for late-onset Pompe disease patients ≥40kg who aren't improving on current enzyme replacement therapy. Fastest path: Have

How to Get Oxlumo (lumasiran) Covered by UnitedHealthcare in Florida: Complete Guide with Forms, Appeals, and Timelines

Answer Box: UnitedHealthcare requires prior authorization for Oxlumo (lumasiran) in Florida, with approval typically requiring: (1) confirmed PH1 diagnosis via AGXT genetic testing, (2) specialist prescriber (nephrologist/geneticist), (3) elevated urinary oxalate levels, and (4) eGFR ≥30 mL/min/1.73 m². First step today: Have your nephrologist or geneticist

If Strimvelis (ADA-SCID Gene Therapy) Isn't Approved by Blue Cross Blue Shield in Florida: Alternative Treatments & Exception Paths

Answer Box: Your Options When Strimvelis Gene Therapy Is Denied If Blue Cross Blue Shield (BCBS) in Florida denies Strimvelis gene therapy for ADA-SCID, you have three main paths: PEG-ADA enzyme replacement therapy as a bridge treatment, allogeneic stem cell transplant if a donor is available, or formulary exception appeal

How to Get Entresto (sacubitril/valsartan) Covered by Cigna in Florida: Appeals, Forms, and Medical Necessity Requirements

Quick Answer: Getting Entresto Covered by Cigna in Florida Fastest path to approval: Submit prior authorization with documented heart failure diagnosis (LVEF ≤40%), NYHA class, and prior ACE inhibitor/ARB failure or intolerance. If denied, file internal appeal within 180 days citing Florida step-therapy protections. Start today: Call Cigna at

Denied for Turalio (pexidartinib) by UnitedHealthcare in Florida? How to Appeal (Templates & Timelines)

Answer Box: Getting Turalio (pexidartinib) Covered by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Turalio (pexidartinib) with strict criteria: confirmed TGCT diagnosis, unresectable disease, and REMS enrollment. If denied, request a peer-to-peer review within 24-72 hours, then file internal appeals within 180 days. Florida offers binding external review through